Champions Oncology, founded in Hackensack, New Jersey, is dedicated to advancing oncology research and drug development. The company offers a range of services including the development of oncology drugs and providing clinical solutions and trials on a global scale. Their core mission is to accelerate oncology research through innovative preclinical and clinical testing services. Champions Oncology's offerings include a clinically relevant living tumor bank and proprietary in vivo and ex vivo platforms, supported by a comprehensive multi-omics data platform.

Notable figures affiliated with Champions Oncology include key researchers and industry experts who contribute to its innovative approaches. The company has achieved significant milestones in oncology drug development and has made substantial contributions to clinical research. Its impact is seen in the acceleration of drug development timelines and the provision of critical data that supports the advancement of cancer treatments worldwide. Through its pioneering platforms and extensive tumor bank, Champions Oncology continues to be a leader in the field of oncology research.